Novartis AG (NVS)
97.11
+0.34
(+0.35%)
USD |
NYSE |
Dec 20, 16:00
97.08
-0.02
(-0.03%)
After-Hours: 20:00
Novartis Total Liabilities (Quarterly): 60.08B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Pfizer Inc | 126.92B |
| PTC Therapeutics Inc | 2.897B |
| Monte Rosa Therapeutics Inc | 109.62M |
| AstraZeneca PLC | 64.12B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.52B |
| Shareholders Equity (Quarterly) | 43.32B |
| Debt to Equity Ratio | 0.6999 |
| Current Ratio | 1.111 |
| Net Debt Paydown Yield | -0.33% |